First Trust Advisors
STOK icon

First Trust Advisors’s Stoke Therapeutics STOK Stock Holding History

First Trust Advisors’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1M Buy
490,913
+327,454
+200% +$10.5M 0.01% 1009
2026
Q1 		$5.32M Buy
163,459
+780
+0.5% +$25.6K ﹤0.01% 1397
2025
Q4 		$5.16M Buy
162,679
+10,380
+7% +$312K ﹤0.01% 1382
2025
Q3 		$3.58M Buy
+152,299
New +$2.61M ﹤0.01% 1548

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

First Trust Advisors's STOK Position: Q2 2026 in Review

First Trust Advisors increased its Stoke Therapeutics (STOK) stake by 200% in Q2 2026, buying an estimated $10.5M and bringing the position to 490,913 shares worth $16.1M. The position accounts for 0.01% of the portfolio, ranked #1009.

First Trust Advisors first reported a position in STOK in Q3 2025 and has held it in 4 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • First Trust Advisors held 490,913 shares of Stoke Therapeutics worth $16.1M as of Q2 2026.
  • First Trust Advisors bought 327,454 Stoke Therapeutics shares in Q2 2026, an estimated $10.5M.
  • Stoke Therapeutics made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #1009 holding.
  • First Trust Advisors first reported a position in Stoke Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.